MetLife Investment Management’s Ocugen OCGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-44,769
| Closed | -$31.6K | – | 2900 |
|
|
2025
Q1 | $31.6K | Sell |
44,769
-125,687
| -74% | -$88.8K | ﹤0.01% | 2726 |
|
|
2024
Q4 | $137K | Buy |
170,456
+80,948
| +90% | +$65.2K | ﹤0.01% | 2482 |
|
|
2024
Q3 | $88.8K | Buy |
89,508
+23,877
| +36% | +$23.7K | ﹤0.01% | 2669 |
|
|
2024
Q2 | $102K | Buy |
+65,631
| New | +$102K | ﹤0.01% | 2595 |
|
|
2023
Q2 | – | Sell |
-116,226
| Closed | -$99.2K | – | 2974 |
|
|
2023
Q1 | $99.2K | Buy |
116,226
+45,303
| +64% | +$38.6K | ﹤0.01% | 2558 |
|
|
2022
Q4 | $92.2K | Sell |
70,923
-41,609
| -37% | -$54.1K | ﹤0.01% | 2624 |
|
|
2022
Q3 | $200K | Hold |
112,532
| – | – | ﹤0.01% | 2304 |
|
|
2022
Q2 | $255K | Buy |
112,532
+45,026
| +67% | +$102K | ﹤0.01% | 2140 |
|
|
2022
Q1 | $223K | Buy |
67,506
+1,523
| +2% | +$5.03K | ﹤0.01% | 2288 |
|
|
2021
Q4 | $300K | Buy |
65,983
+9,087
| +16% | +$41.3K | ﹤0.01% | 1811 |
|
|
2021
Q3 | $409K | Sell |
56,896
-10,891
| -16% | -$78.2K | ﹤0.01% | 1644 |
|
|
2021
Q2 | $544K | Buy |
+67,787
| New | +$544K | ﹤0.01% | 1518 |
|